课题基金 / 基金详情

项目摘要

项目成果

Richard Brian Meagher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose there are two classes of actin-based cytoskeletal systems, vegetative (VEG) and reproductive (REP), which have functioned and evolved with relative independence for more than 350 million years in vascular plants, similar to the cytoplasmic and muscle actin systems in vertebrates. To understand the relative importance of differences in gene regulation and protein isovariant sequence, we examined the gene families encoding eight actins (ACT), five profilins (PRF), eleven actin depolymerizing factors (ADF), and six nuclear actin-related proteins (ARP). The ACT, ADF, and PRF cytoskeletal families contained ancient subclasses of genes with VEG or REP expression patterns, while the ARPs were constitutively expressed. Knockout and knockdown alleles among the ACT, ADF, PRF, and ARP genes revealed numerous and diverse phenotypic defects in every stage of multicellular development. We constructed highly synthetic healthy plants with a single VEG actin isovariant to demonstrate the importance of VEG gene regulation. We were able to suppress ectopic REP actin gene expression with REP, but not VEG, ADFs and PRFs demonstrating the importance of isovariant-specific interactions. While ACT, ADF, and PRF defects resulted in alterations in the cytoskeleton, a few alleles shared epigenetic changes in transcription factor gene expression leading to altered development with ARP mutants. Because nuclear ARPs are known to function primarily in chromatin remodeling complexes containing conventional actin subunits, these results led to a new proposal: the transcriptional expression of master regulators of development is controlled by conventional actins functioning in chromatin remodeling complexes, with the level of actin in the nucleus controlled by ADFs and PRFs. Our Specific Aims in the next grant period are: 1) to characterize the phenotypes of ACT, ADF, and PRF mutants; 2) to characterize gene and isovariant specific interactions and their roles in multicellular development; and 3) to explore how the roles of these proteins are balanced between nuclear epigenetic and cytoplasmic cytoskeletal functions. Differences among protein isovariants and their differential regulation are now widely recognized to play an essential role in animal multicellular development. Undoubtedly, our experimental designs and research outcomes outline a path for such studies in molecular medicine (e.g., human nemaline actin mutations).
期刊论文(51)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0145917
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Roy-Zokan EM, Dyer KA, Meagher RB]
通讯作者: Meagher RB
DOI: 10.1016/s1937-6448(09)77005-4
发表时间: 2009
期刊: INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY
影响因子: --
作者: [Meagher, Richard B., Kandasamy, Muthugapatti K., McKinney, Elizabeth C., Roy, Eileen]
通讯作者: Roy, Eileen
DOI: 10.1017/s0016672303006311
发表时间: 2003
期刊: Genetical research
影响因子: --
作者: [Liu,Renyi, Ferrenberg,AlanM, Gilliland,LauraU, Meagher,RichardB, Asmussen,MarjorieA]
通讯作者: Asmussen,MarjorieA
Recombination within a subclass of restriction fragment length polymorphisms may help link classical and molecular genetics.
限制性片段长度多态性子类内的重组可能有助于将经典遗传学和分子遗传学联系起来。
DOI: 10.1093/genetics/120.3.809
发表时间: 1988
期刊: Genetics
影响因子: 3.3
作者: [Meagher,RB, McLean,MD, Arnold,J]
通讯作者: Arnold,J
13
    Targeted pan-antibacterial liposomes to control pathogenic mycobacteria
    • 批准号:
      10569282
    • 项目类别:
    • 资助金额:
      $18.88万
    • 财政年份:
      2023
    • 负责人:
      Richard Brian Meagher
    • 依托单位:
    Targeted delivery of antifungal drug loaded liposomes to control mucormycosis
    • 批准号:
      10668509
    • 项目类别:
    • 资助金额:
      $22.65万
    • 财政年份:
      2022
    • 负责人:
      Richard Brian Meagher
    • 依托单位:
    Targeted delivery of antifungal drug loaded liposomes to control mucormycosis
    • 批准号:
      10509943
    • 项目类别:
    • 资助金额:
      $18.88万
    • 财政年份:
      2022
    • 负责人:
      Richard Brian Meagher
    • 依托单位:
    Antifungal Liposomes Targeted to Cell Wall Mannans
    • 批准号:
      9979038
    • 项目类别:
    • 资助金额:
      $22.65万
    • 财政年份:
      2020
    • 负责人:
      Richard Brian Meagher
    • 依托单位:
    海外基金